Episode 34: Control of Breathing
Dr. Lance Wheeler, DVM, DACVECC
INTRODUCTION: WHY RESPIRATORY CONTROL MATTERS
Hey everyone, welcome back to Wheeler the Healer: Small Animal Emergency and Critical Care—practical ECC education to keep you sharp when it matters most.
My name is Lance Wheeler, and I’m a small animal emergency and critical care specialist.
Last episode, we wrapped up our initial section on core critical care concepts by talking about predictive scoring systems and how those tools can support clinical reasoning without replacing bedside judgment. We also officially opened the next major block of this series: respiratory disorders. So now we’re starting to build the physiologic framework underneath everything that comes next. Before we can really understand hypoventilation, oxygen therapy, upper airway obstruction, pulmonary disease, pleural space disease, or mechanical ventilation, we first need to answer a more basic question: who’s actually controlling breathing in the first place?
Now fair warning — this episode is definitely more physiology-heavy than many of the others in this series, and some of these concepts have less direct bedside application in day-to-day ECC practice. But this material is extremely important for anyone studying for boards or trying to build a deeper understanding of respiratory physiology, ventilatory control, and mechanical ventilation. And to help keep things clinically grounded, I’ve also pulled in several veterinary studies so we can connect these mechanisms back to real ECC patients.
The material for today is based on Small Animal Critical Care Medicine, 3rd edition, Chapter 14, “Control of Breathing,” by Kate Farrell.
Every respiratory patient you see—from the brachycephalic dog struggling to breathe to the pulmonary edema patient breathing 80 times per minute—illustrates the interaction between respiratory mechanics and the neural control of breathing.
The reality is this: breathing is not just air moving in and out. It’s a continuously adapting neurologic control system integrating blood gases, pH, stretch receptors, airway irritation, pain, temperature, voluntary control, emotional state, and metabolic demand in real time, second by second, breath by breath.
Conceptually, this chapter is really about integration. The body constantly has to decide:
How much ventilation is needed right now?
Should breathing become faster or deeper?
Should inspiration end sooner?
Should expiration become active?
Should airway resistance change?
Should breathing briefly pause during swallowing or vomiting?
And the answer comes from a massive distributed network involving the medulla, pons, cortex, chemoreceptors, pulmonary receptors, peripheral sensory receptors, and respiratory muscles.
So the goal today is to walk through how breathing rhythm is generated, how respiratory timing is coordinated, how carbon dioxide and oxygen alter ventilation, how airway and lung receptors modify respiratory patterns, and how disease and drugs disrupt this exquisitely fine-tuned system in veterinary ECC patients.
As I call out key numbers or define important terms, take a second to repeat them to yourself. That repetition helps reinforce what you already know and lock in the details that are most testable. At the end, we’ll review them again during the rapid-fire board review so you can reinforce them one more time.
FOUNDATIONS OF RESPIRATORY CONTROL
Breathing is automatically initiated by the central nervous system, or CNS, and it starts incredibly early in life. Respiratory rhythm develops in the fetal brainstem during pregnancy and then persists continuously throughout life. Most of the time, breathing occurs without conscious awareness. Your medulla is quietly keeping you alive while you sleep, work, drive, or run CPR.
But breathing is not just automatic. It’s modifiable. The respiratory rhythm can be altered voluntarily by the cortex, reflexively by airway and pulmonary receptors, and chemically by chemoreceptors responding to changes in blood gases and pH.
At the end of the day, the purpose of this entire system is to maintain oxygenation, eliminate carbon dioxide, and stabilize acid-base balance while continuously adapting to metabolic demand.
And one of the major concepts here is that respiratory control is distributed. There is no single “master breathing neuron.” Respiratory rhythm emerges from interconnected neuronal populations functioning together as a network.
Before we dive into all the individual nuclei and neuron groups, let’s simplify the big picture.
If you’re starting to feel like there are a lot of names flying around, don’t worry. For board purposes, you really only need to remember three levels of control.
First, the medulla generates the rhythm.
Second, the pons shapes the pattern.
And third, higher brain centers modify breathing based on behavior, emotion, voluntary control, and metabolic demands.
If you understand those three levels, all of the individual structures we’re about to discuss become much easier to organize.
THE MEDULLA: RESPIRATORY RHYTHM GENERATION
Let’s start with the medulla.
The medulla is the primary respiratory control center. It generates respiratory rhythm, integrates incoming sensory information, and coordinates output to the respiratory muscles.
Within the medulla is the respiratory central pattern generator. This is a network of interconnected neurons that continuously produces rhythmic bursts of activity. You can think of the central pattern generator as a metronome, generating the basic timing signal that keeps breathing going, breath after breath.
One region within that network deserves special attention: the pre-Bötzinger complex. If there’s a single structure most closely associated with respiratory rhythm generation, it’s this one. The pre-Bötzinger complex is considered one of the major rhythm generators for breathing and is heavily concentrated with the neurons responsible for producing those repetitive inspiratory bursts.
A 2017 study by Edward Zuperku and colleagues, titled “Characteristics of Breathing Rate Control Mediated by a Subregion Within the Pontine Parabrachial Complex,” provides a useful example of how breathing rate can be modified by neuronal activity outside the primary medullary rhythm-generating regions. We’ll come back to this study when we discuss the pons.
Now, generating rhythm is only part of the job. The medulla also has to integrate information and coordinate respiratory muscle activity.
That’s where the dorsal and ventral respiratory groups come in.
The dorsal respiratory group functions primarily as an inspiratory integration center. Located near the nucleus tractus solitarius, it receives sensory information arriving through the glossopharyngeal and vagus nerves. Those inputs include information about pH, oxygen, carbon dioxide, blood pressure, and pulmonary stretch. You can think of the dorsal respiratory group as one of the major information-processing centers of the respiratory network.
The ventral respiratory group, or VRG, is more diverse. It contains both inspiratory and expiratory neurons and contributes to respiratory force generation, active expiration, and upper airway control.
Several additional nuclei within the ventral respiratory group contribute to inspiratory force generation, expiratory control, and upper airway function. For board purposes, it’s more important to understand those roles than to memorize every individual nucleus.
One structure worth knowing is the nucleus ambiguus, which supplies motor innervation to muscles of the pharynx and larynx. Tongue muscles are primarily controlled by the hypoglossal nucleus. Another is the Bötzinger complex, in the rostral ventral respiratory column near the retrofacial nucleus, which contains important expiratory neurons that help shape respiratory timing.
So if we zoom back out for a second, the medulla is really doing three jobs. The pre-Bötzinger complex helps generate the rhythm. The dorsal respiratory group processes incoming information. And the ventral respiratory group helps coordinate respiratory force and airway control. Together, those structures form the core respiratory control network.
So far we’ve built the rhythm generator. Next we’re going to talk about the structure that fine-tunes that rhythm: the pons.
THE PONS: RESPIRATORY TIMING AND PATTERN
Now let’s move up one level to the pons.
The medulla contains the primary respiratory rhythm-generating networks, while the pons plays a major role in shaping and refining respiratory timing.
Historically, this region was called the pneumotaxic center. Today we generally refer to it as the pontine respiratory group. Its primary role is to fine-tune respiratory timing, stabilize breathing patterns, and coordinate the transition between inspiration and expiration.
One way to think about it is this: the medulla decides that breathing should happen, while the pons helps determine exactly when inspiration should stop and expiration should begin.
Experimental evidence shows that pontine signals influence both the termination of inspiration and the timing of the next breath, depending on which neurons are activated and when. In their 2017 study, Edward Zuperku and colleagues investigated a subregion of the pontine parabrachial complex in dogs and found that stimulation could increase breathing frequency primarily by shortening expiration and triggering the next inspiration.
There’s also the classic apneustic center within the caudal pons. Excitatory signals from this region tend to prolong inspiration. Under experimental conditions, disconnecting the apneustic center from the pontine respiratory group while also transecting the vagus nerves can produce apneusis—prolonged inspiratory gasping interrupted only by brief ineffective expirations.
HIGHER BRAIN CENTERS AND VOLUNTARY CONTROL
Finally, above both the medulla and pons sit the higher brain centers.
The cortex allows voluntary control of breathing. This is how you consciously hold your breath, speak, sing, or deliberately alter your respiratory pattern.
The hypothalamus and limbic system modify breathing based on emotional state, temperature, pain, stress, fear, exercise, hypoxia, and hypercapnia. Think about the terrified cat in an oxygen cage breathing 80 breaths per minute. Some of that is pulmonary disease. Some of it is emotional circuitry.
So if you remember nothing else from this entire neuroanatomy section, remember this hierarchy:
The medulla generates the rhythm.
The pons shapes the pattern.
Higher brain centers modify breathing based on behavior, emotion, and voluntary control.
Everything else is really just filling in the details.
RESPIRATORY MUSCLES AND MOTOR OUTPUT
Now, all of that neural control is ultimately useless unless it can be translated into movement.
The respiratory centers can generate rhythm, integrate sensory information, and adjust breathing patterns all day long, but at the end of the process they still have to activate muscles. Every breath ultimately depends on respiratory muscles contracting at the right time, with the right force, and in the right sequence.
So let’s shift from the control centers themselves and talk about the machinery they control: the respiratory muscles.
And this matters clinically because generating a respiratory signal is only part of the process. Effective ventilation also requires the respiratory muscles to respond appropriately.
So before we talk about how breathing is regulated chemically, let’s spend a minute talking about the machinery that actually moves air.
Inspiratory muscles primarily include the diaphragm, chest wall muscles, and some neck muscles.
Active expiration recruits abdominal muscles, and chest wall musculature.
And upper airway resistance is heavily influenced by muscles of the pharynx, larynx, and tongue.
Everything we’ve discussed so far explains how breathing can occur.
We’ve talked about the neural circuitry that generates respiratory rhythm, coordinates muscle activity, and produces a breath.
Now we’re going to talk about why breathing changes.
And in many ways, everything that follows can be summarized by a single question:
How much ventilation does the body need right now?
At the center sits the medulla, continuously integrating information from all over the body and trying to answer that question. The chemoreceptors, pulmonary receptors, musculoskeletal receptors, and higher brain centers we’ve discussed all provide pieces of information that help shape the answer.
CHEMORECEPTORS AND BLOOD GAS REGULATION
Now we arrive at one of the most important sections in the entire chapter: chemoreceptors and blood gas regulation. And if there is one section from today’s episode that explains why patients breathe faster, slower, deeper, or shallower, this is probably it.
Ventilation is fundamentally regulated through feedback loops. The primary controlled variables are PaCO2, pH, and PaO2, and the body monitors those variables using two major classes of chemoreceptors: central chemoreceptors and peripheral chemoreceptors.
Before we discuss either one individually, remember this key concept: in healthy individuals, carbon dioxide is the dominant driver of ventilation. Carbon dioxide is the major physiologic regulator of breathing in health, and understanding how the body senses CO2 helps explain a huge amount of respiratory physiology.
Let’s start with the central chemoreceptors. These receptors are located primarily on the ventrolateral surface of the medulla, although other chemosensitive regions may also contribute. Importantly, central chemoreceptors do not primarily respond to oxygen. Their major stimulus is brain interstitial fluid pH.
And the mechanism here is incredibly board relevant. If you understand remember this concept, a huge amount of respiratory physiology suddenly starts making more sense.
Carbon dioxide crosses the blood-brain barrier freely, whereas hydrogen ions and bicarbonate ions do not cross nearly as readily. So when arterial PaCO2 rises, CO2 rapidly diffuses into the cerebrospinal fluid, or CSF, and brain interstitium where it combines with water to form carbonic acid.
And know this equation for the bicarbonate buffer system:
CO2 + H2O ↔ H2CO3 ↔ HCO3– + H+
Don’t get lost in the chemistry. The board-relevant takeaway is simple: higher CO₂ creates more hydrogen ions in the CSF, lowers pH, and stimulates breathing.
As CO2 accumulates in the CSF, the reaction shifts to the right, generating additional hydrogen ions and lowering pH. The CSF has relatively poor buffering capacity because it contains far lower protein concentrations than blood, so even small increases in CO2 can produce substantial changes in hydrogen ion concentration and pH. Another important number is that brain and CSF PCO2 are typically about 5 to 10 mm Hg higher than arterial PCO2. Hypercapnia also causes cerebral vasodilation, affecting cerebral blood flow and carbon dioxide exchange.
The end result is increased ventilation through changes in respiratory rate and depth. In fact, central chemoreceptors account for roughly 60% to 80% of the ventilatory response to carbon dioxide. One study in awake dogs found central chemoreceptors contributed approximately 63% of the steady-state hypercapnic response, although there was significant variability between individual dogs.
Now here’s the clinically important adaptation. If hypercapnia persists for several hours, bicarbonate compensation within the CSF begins to partially restore extracellular pH. Over time, this blunts ventilatory responsiveness to carbon dioxide. That’s the basis for chronic hypercapnic adaptation. In other words, chronic hypercapnia can reset respiratory drive sensitivity. And that leads directly into one of the classic respiratory physiology discussions: oxygen-induced hypercapnia.
In patients with chronic hypercapnic respiratory disease, responsiveness to elevated carbon dioxide gradually diminishes over time as central chemoreceptors adapt. As a result, hypoxemia can become a more important ventilatory stimulus.
The classic example comes from human chronic obstructive pulmonary disease, or COPD. In some chronically hypercapnic patients, excessive oxygen supplementation can worsen hypercapnia through several mechanisms, including altered ventilation-perfusion matching, the Haldane effect, and, in some cases, reduced ventilatory drive. How often clinically significant oxygen-induced hypercapnia occurs in veterinary patients is less well established, but the underlying physiology illustrates how respiratory control can adapt over time.
Clinically, this is one reason we generally target adequate oxygenation rather than chasing normal oxygen values in chronically hypercapnic patients. The physiology is more complex than simply “removing hypoxic drive,” and modern evidence suggests multiple mechanisms contribute to oxygen-induced hypercapnia. But the core concept remains important: respiratory control can adapt over time, and oxygen therapy should be viewed as a drug with physiologic effects rather than as a completely benign intervention.
Now let’s move to the peripheral chemoreceptors.
These receptors are located within the carotid bodies near the carotid bifurcation and the aortic bodies along the aortic arch. The carotid bodies are the major respiratory chemoreceptors, whereas the aortic bodies appear to exert greater influence on cardiovascular responses.
Unlike central chemoreceptors, peripheral chemoreceptors respond rapidly—within about 1 to 3 seconds—to decreases in PaO2, increases in PaCO2, increases in hydrogen ion concentration, and reductions in perfusion. Know that timing. Peripheral chemoreceptors are fast responders and are particularly important for detecting acute physiologic changes.
And as a quick ECC trivia fact, these same carotid body tissues can give rise to chemodectomas, which are tumors derived from peripheral chemoreceptor tissue.
Oxygen sensing occurs in specialized type I glomus cells within the carotid bodies. Hypoxia inhibits potassium channels within these cells, leading to neurotransmitter release and activation of afferent pathways. Potential mediators include reactive oxygen species, carbon monoxide, and hydrogen sulfide. The resulting signals travel through the carotid sinus nerve, a branch of the glossopharyngeal nerve, and through vagal afferents from the aortic bodies.
Activation of peripheral chemoreceptors increases ventilatory drive and can also produce autonomic responses, including changes in heart rate, vascular tone, and catecholamine release. Importantly, the cardiovascular response depends on the circumstances; bradycardia is not an inevitable response in a spontaneously breathing patient.
At this point we’ve discussed central chemoreceptors and peripheral chemoreceptors separately.
Now let’s step back and see how they work together in a real patient.
Remember that carbon dioxide is normally the dominant driver of ventilation. The ventilatory response to rising PaCO₂ is approximately linear over much of the physiologic range. As PaCO₂ increases, respiratory drive increases, stimulating greater ventilation to eliminate excess carbon dioxide. Hypoxemia and metabolic acidosis further amplify this hypercapnic ventilatory response.
Oxygen behaves differently. The oxygen-ventilation relationship is hyperbolic rather than linear. This is extremely testable. PaO2 usually must fall below approximately 50 to 60 mm Hg before major increases in ventilation occur. That’s much lower than many clinicians expect. Above that threshold, changes in PaO2 have relatively small effects on respiratory drive. But once PaO2 falls below about 50 to 60 mm Hg, ventilation rises sharply. Concurrent hypercapnia magnifies this hypoxic ventilatory response, and exercise or metabolic acidosis can further enhance it even in the absence of hypercapnia.
Before we move on, there are a few interesting physiologic nuances worth mentioning.
Traditionally, we teach that peripheral chemoreceptors respond primarily to oxygen tension rather than oxygen content. Under that model, anemia would have relatively little direct effect on chemoreceptor activity. However, some evidence suggests the relationship may be more complex, and anemia itself may directly stimulate peripheral chemoreceptors.
The important takeaway is that oxygen tension and oxygen content are not necessarily the same thing physiologically.
Temperature also matters. Increased blood temperature stimulates peripheral chemoreceptors and enhances responses to both hypoxia and hypercapnia.
So far we’ve been talking about sensors that monitor blood chemistry.
Chemoreceptors monitor things like oxygen, carbon dioxide, pH, and perfusion.
The next group of receptors monitor something different: what’s actually happening inside the lungs and airways themselves.
PULMONARY AND AIRWAY RECEPTORS
Now let’s move beyond chemoreceptors and talk about pulmonary and airway receptors.
These receptors provide continuous feedback about what is happening inside the lungs and airways and help fine-tune respiratory activity from breath to breath.
Let’s start with pulmonary stretch receptors.
These receptors are located within airway smooth muscle and respond to excessive or sustained lung inflation. Signals travel through the vagus nerve and inhibit inspiration through the Hering–Breuer inflation reflex.
Know that reflex. The Hering–Breuer inflation reflex is essentially the lung’s built-in anti-overinflation mechanism. As lung volume increases, stretch receptor activation helps terminate inspiration and slow the respiratory rate. There is also a complementary deflation reflex that promotes inspiration when lung volume falls.
A second group consists of irritant receptors located throughout the upper and lower airways. These receptors respond to things like dust, cold air, chemical irritation, noxious gases, and mechanical stimulation.
Activation produces many of the protective airway reflexes we encounter clinically, including coughing, sneezing, bronchoconstriction, mucus secretion, laryngeal spasm, and increased respiratory rate.
One particularly clinically relevant receptor population in ECC patients is the J receptor, also called the juxtacapillary receptor.
These receptors are located within the pulmonary interstitium adjacent to pulmonary capillaries and respond to pulmonary capillary distension, interstitial edema, and various chemicals circulating through the lungs. Their signals travel through slowly conducting, nonmyelinated vagal C fibers.
Activation of J receptors produces rapid shallow breathing and, in severe cases, apnea. Clinically, they are thought to contribute significantly to the sensation of dyspnea in diseases such as left-sided congestive heart failure, pulmonary edema, and interstitial lung disease.
And honestly, this is one of those concepts that suddenly makes pulmonary edema patients make more sense.
That frantic patient breathing 80 breaths per minute isn’t responding only to hypoxemia. Fluid accumulating within the pulmonary interstitium may also activate J receptors directly, contributing to respiratory discomfort and rapid, shallow breathing.
In other words, pulmonary edema doesn’t just impair gas exchange. It can also stimulate sensory pathways that promote faster, shallower breathing.
Of course, breathing is influenced by much more than just chemoreceptors and pulmonary receptors.
OTHER SENSORY INFLUENCES ON BREATHING
Other sensory systems throughout the body continuously modify respiratory activity as well. Arterial baroreceptors primarily regulate cardiovascular function, but severe hypotension can trigger reflex hyperventilation, whereas severe hypertension can promote hypoventilation.
Muscle, tendon, and joint receptors provide information about movement, muscle tension, lung expansion, and work of breathing. These receptors contribute substantially to exercise-induced hyperventilation. Pain receptors can trigger an initial period of apnea followed by hyperventilation, while elevated body temperature can independently stimulate ventilation.
And once again, this reinforces the major theme of the chapter: respiratory control is massively integrated. Breathing is not controlled by a single center or a single stimulus. It reflects the combined influence of neurologic, chemical, mechanical, cardiovascular, metabolic, and behavioral inputs all occurring simultaneously.
DISORDERS AND DRUGS AFFECTING RESPIRATORY CONTROL
Now let’s finish with abnormalities in respiratory control.
This entire system is exquisitely fine-tuned, which means it is also remarkably easy to disrupt. Virtually any central nervous system depressant can impair ventilation. Most general anesthetics produce dose-dependent ventilatory depression, and both opioids and benzodiazepines blunt ventilatory responsiveness to hypercapnia and hypoxemia.
A 2023 study by Barbara Palkovic and colleagues examining remifentanil-induced respiratory depression in decerebrate dogs provides an elegant reminder that opioid respiratory depression is not simply a matter of “making the patient sleepy.” Remifentanil reduced neuronal activity across several respiratory-related brainstem regions, including the pre-Bötzinger and Bötzinger complexes and the pontine respiratory group.
An especially interesting aspect of this experimental work is that opioid-associated bradypnea can involve a marked prolongation of expiration, delaying initiation of the next breath. At higher doses, inspiratory motor output can also be impaired. That’s a high-level respiratory physiology pearl, but it illustrates why opioid-induced respiratory depression involves more than simply weakening an inspiratory effort.
On the opposite end of the spectrum, doxapram acts as a respiratory stimulant through peripheral and central mechanisms. A 2023 case report described a dog with severe postoperative hypoventilation following cervical vertebral stabilization in which a doxapram infusion supported ventilation when continued mechanical ventilation was not feasible. That is a single case report, not evidence that doxapram should routinely replace mechanical ventilation. Other respiratory stimulants include aminophylline, theophylline, caffeine, and progesterone.
Respiratory control can also be disrupted by intrinsic disease. Hypoventilation, traumatic brain injury, intracranial hypertension, and various neurologic disorders can all interfere with normal respiratory rhythm generation and ventilatory control. We’ll revisit many of those topics later in the respiratory section and again during neurologic critical care discussions.
PUTTING IT ALL TOGETHER
So before we wrap up, let’s zoom back out one final time and tie everything together.
At this point we’ve covered dozens of structures, receptors, pathways, and reflexes. It can feel like a lot of moving parts. But they’re all trying to solve the same problem.
At the center of that entire system sits the medulla, continuously integrating information from all of those sources and answering the same question we’ve been returning to throughout this episode:
How much ventilation does the body need right now?
Some inputs stimulate ventilation. These include hypoxia, hypercapnia, acidosis, pain, muscle and joint activity, irritant receptors, and J receptors. Other inputs, such as pulmonary stretch receptors, primarily inhibit inspiratory drive.
All of those signals ultimately influence respiratory muscle activity and determine a single outcome: how much ventilation is required right now.
In many ways, that’s the central question of the entire chapter. Every second of every day, the body is continuously asking:
“How much breathing do we need right now?”
And this remarkably complex network is constantly negotiating the answer.
CLINICAL APPLICATION: INTERPRETING RESPIRATORY SIGNS
Before we move to the board review, let’s briefly bring this back to the bedside.
In 2021, Domínguez-Ruiz and colleagues evaluated how consistently clinicians recognized respiratory examination findings in dogs and cats with abnormal breathing patterns. Agreement was surprisingly poor for many respiratory signs, with sufficient interclinician agreement for only a handful of findings, including stertor, stridor, attenuated heart or lung sounds, and goose-honking respiratory sounds in dogs, and stertor and open-mouth breathing in cats. They also found that agreement decreased as differences in clinician experience increased.
The practical takeaway is simple: respiratory examinations are valuable, but standardized terminology, repeated examinations, and integration with diagnostics remain essential.
If you only remember three things from today’s episode, remember this: the medulla generates the rhythm, carbon dioxide is the dominant driver of ventilation, and the body doesn’t care about breathing itself—it cares about matching ventilation to metabolic demand.
RAPID-FIRE BOARD REVIEW
The medulla is the primary respiratory center.
The pre-Bötzinger complex functions as a major central rhythm generator.
Breathing rhythm emerges from interconnected neuronal populations rather than a single neuron.
The respiratory cycle has three phases: inspiration, postinspiration, and expiration.
Inspiration is an active process.
Quiet expiration is mostly passive.
Active expiration recruits abdominal and chest wall musculature.
The dorsal respiratory group primarily integrates sensory information relevant to inspiration, including vagal and glossopharyngeal afferent input.
Inspiratory output from medullary respiratory networks ultimately activates phrenic motor neurons, which drive diaphragmatic contraction.
The ventral respiratory group contains both inspiratory and expiratory neurons.
The pontine respiratory group fine-tunes respiratory timing.
The pontine respiratory group was historically called the pneumotaxic center.
Pontine respiratory networks help regulate inspiratory termination and the timing of the next breath; some pontine inputs can increase breathing rate by shortening expiration.
Apneusis consists of prolonged inspiratory gasping with brief ineffective expiration.
Chemoreceptors regulate ventilation through feedback loops involving: PaCO2, pH, and PaO2.
Central chemoreceptors primarily respond to CO2 and pH.
Peripheral chemoreceptors respond to: oxygen, CO2, pH, and perfusion.
Carbon dioxide crosses the blood-brain barrier freely.
Hydrogen and bicarbonate ions do not cross readily.
Chronic hypercapnia blunts ventilatory responsiveness to CO2.
Peripheral chemoreceptors respond within 1–3 seconds.
Carbon dioxide is the dominant driver of ventilation in health.
Central chemoreceptors contribute about 60%–80% of the ventilatory response to CO2.
The ventilatory response to increasing PaCO₂ is approximately linear over much of the physiologic range.
The oxygen-ventilation relationship is hyperbolic.
PaO2 usually must fall below approximately 50–60 mm Hg before major increases in ventilation occur.
Hypoxemia and metabolic acidosis amplify hypercapnic ventilatory responses.
The Hering–Breuer inflation reflex protects against overinflation.
J receptors are juxtacapillary receptors in the pulmonary interstitium.
J receptor stimulation can produce rapid shallow breathing or apnea.
Opioids and benzodiazepines impair ventilatory responsiveness.
Doxapram stimulates respiration through central and peripheral effects.
Additional respiratory stimulants include: aminophylline, theophylline, caffeine, and progesterone.
OUTRO
Thank you for listening—I really appreciate you spending this time with me.
If you found this helpful, make sure to follow or subscribe so you don’t miss future episodes as we work through core ECC topics together.
If you know someone who’s studying for boards or working in emergency and critical care, feel free to share this with them—this is meant to be something we can all learn from together.
And if you have a minute, leaving a rating or review really helps more people find the podcast—and it also helps me understand what’s most useful so I can continue to adapt and focus on the topics that matter most to you.
You can also visit WheelerTheHealer.com, where you’ll find full episode videos, transcripts, rapid-fire board reviews, references, and additional educational resources. The video version of Wheeler the Healer is available on YouTube, and you can find additional educational content from my colleague Igor Yankin through VetEMCrit.
Thanks again for being here, and I’ll see you in the next episode.
Stay sharp out there.
Long Days and Pleasant Nights.
